Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages-Reference-Cited by-同舟云学术

Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages

Published:2021-11-13 Issue:2 Volume:29 Page:583-592
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Grüter Thomas¹²^ORCID,Motte Jeremias¹²^ORCID,Bulut Yesim¹²,Kordes Anna¹²,Athanasopoulos Diamantis¹²^ORCID,Fels Miriam¹²,Schneider‐Gold Christiane¹,Gold Ralf¹²,Fisse Anna Lena¹²^ORCID,Pitarokoili Kalliopi¹²

Affiliation:

1. Department of Neurology, St. Josef‐Hospital Ruhr‐University Bochum Bochum Germany

2. Immunmediated Neuropathies Biobank (INHIBIT) Ruhr‐University Bochum Bochum Germany

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.15156

Reference43 articles.

1. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

2. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher